Biomarkers for Cancer Diagnosis

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to presence of cancer. Genetic, epigenetic, proteomic, glycolic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. While some cancer biomarkers can be used to predict how aggressively your cancer will grow, and are therefore useful for assessing your prognosis, the most promising use of biomarkers today is to identify which therapies a patient’s cancer may or may not respond to.


    Related Conference of Biomarkers for Cancer Diagnosis

    August 08-09, 2024

    20th World Congress on Healthcare & Technologies

    London, UK
    September 09-10, 2024

    3rd Global Summit on Physiology and Metabolism of Thyroid

    Paris, France
    September 18-19, 2024

    29th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    September 19-20, 2024

    20th Global Biomarkers and Clinical Research Summit

    Paris, France
    November 11-12, 2024

    9th Global Summit on Midwifery and Womens Health

    Dubai, UAE
    November 22-23, 2024

    5th Global Summit on Public Health

    Paris, France
    November 25-26, 2024

    10th World Holistic Nursing Conference

    Bali, Indonesia
    November 25-26, 2024

    4th International conference on Healthcare Summit

    Bali, Indonesia
    November 28-29, 2024

    World Vaccine Meet 2024

    Bali, Indonesia
    January 27-28, 2025

    10th World Congress on Public Health and Nutrition

    Bangkok, Thailand
    April 07-08, 2025

    7th World Summit on Women's Health and Cancer Awareness

    Vancouver, Canada
    July 24-25, 2025

    36th European Heart and Heart Failure Congress

    Paris, France

    Biomarkers for Cancer Diagnosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in